Matthew Strobeck

Matthew Strobeck serves as director at Biodesix, Inc. (BDSX). This page tracks their complete SEC Form 4 insider trading history including stock purchases and sales.

Total Buys

5 trades

$6.01M

Total Sells

0 trades

$0.00

Net Position

Net Buyer

$6.01M

Companies Traded

2

QDEL, BDSX

Active Period

Dec 2021 – Feb 2026

5 total trades

Most Recent

Buy QDEL

Feb 13, 2026 · $239.6K

Matthew Strobeck's Insider Trading at Biodesix, Inc. (BDSX)

Buys

4 · $5.77M

Sells

0 · $0.00

Total Shares Bought

3,974,680

Total Shares Sold

0

BDSX Price Chart

Loading chart...

Date	Type	Shares	Avg Price	Value	Shares After
Nov 5, 2024↗	Buy	40,000	$1.40	$55.9K	0
Nov 21, 2022↗	Buy	2,669,562	$1.15	$3.07M	0
Apr 7, 2022↗	Buy	1,117,318	$1.79	$2.00M	0
Dec 30, 2021↗	Buy	147,800	$4.35	$642.9K	0

Matthew Strobeck's Insider Trading at QuidelOrtho Corporation (QDEL)

Buys

1 · $239.6K

Sells

0 · $0.00

Total Shares Bought

10,000

Total Shares Sold

0

QDEL Price Chart

Loading chart...

Date	Type	Shares	Avg Price	Value	Shares After
Feb 13, 2026↗	Buy	10,000	$23.96	$239.6K	27,775

Related Insiders

Chris Vazquez

officer: Chief Accounting Officer

BDSXSell · Feb 23, 2026

Scott Hutton

President & CEO

BDSXSell · Feb 23, 2026

Kieran O'Kane

Chief Commercial Officer

BDSXSell · Feb 23, 2026

Kieran O'Kane

officer: Chief Commercial Officer

BDSXSell · Feb 23, 2026

Gary Anthony Pestano

Chief Development Officer

BDSXSell · Feb 23, 2026

Gary Anthony Pestano

officer: Chief Development Officer

BDSXSell · Feb 23, 2026

Chris Vazquez

Chief Accounting Officer

BDSXSell · Feb 23, 2026

Robin Harper Cowie

CFO, Sec'y & Treasurer

BDSXSell · Feb 23, 2026

Explore More Insider Trading Data

BDSX Insider Trading Activity

View all insider trades at Biodesix, Inc.

Healthcare Sector Insider Trades

See insider activity across healthcare stocks

Latest Insider Buys

Most recent insider purchases across all stocks

CEO Stock Purchases

Track CEO buying activity